Share Name Share Symbol Market Type Share ISIN Share Description
Carclo Plc LSE:CAR London Ordinary Share GB0001751915 ORD 5P
  Price Change % Change Share Price Shares Traded Last Trade
  -0.12 -1.84% 6.39 14,322 16:35:01
Bid Price Offer Price High Price Low Price Open Price
6.12 6.66 0.00 0.00 0.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Chemicals 144.85 -14.65 -25.40 5
Last Trade Time Trade Type Trade Size Trade Price Currency
16:10:13 O 1,997 6.22 GBX

Carclo (CAR) Latest News

More Carclo News
Carclo Takeover Rumours

Carclo (CAR) Discussions and Chat

Carclo (CAR) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2020-06-05 15:10:156.221,997124.21O
2020-06-05 14:13:556.225,000311.00O
2020-06-05 09:17:386.717,325491.53O
View all Carclo trades in real-time

Carclo (CAR) Top Chat Posts

Carclo Daily Update: Carclo Plc is listed in the Chemicals sector of the London Stock Exchange with ticker CAR. The last closing price for Carclo was 6.51p.
Carclo Plc has a 4 week average price of 4.50p and a 12 week average price of 3.10p.
The 1 year high share price is 26.50p while the 1 year low share price is currently 3.10p.
There are currently 73,286,918 shares in issue and the average daily traded volume is 129,242 shares. The market capitalisation of Carclo Plc is £4,683,034.06.
rivaldo: Good to see buying coming in now at 7.88p. The share price was at 5.25p or so before the info about the COVID-19 response was posted, so a 50% jump isn't too bad at all.... Last year's year end update was on 17th April, so I'm assuming this year's is coming soon. Judging by the article from the USA, trading and prospects at CAR's global medical facilities should be terrific. This will probably be slightly offset by reduced forecasts for the much smaller Aerospace division during the virus lockdown. As an aside, by pure luck the timing of the disposal of Wipac in late 2019 for a total £11.5m was perfect given the collapse in the auto industry since then (which imo is unlikely to ever recover to prior levels, but that's another story). At least that's one thing the management here got right.
wigwammer: Baner - in fairness I take reds point about growth. Maintenance spend in line with depreciation will keep the business ticking over, but growth will be harder to come by. But as I previously suggest, if £5m or 7p a share is being moved into the coffers of equity holders each year, that's - very decent return from a (now) sub 10p share price base.
wigwammer: Another fact is - it isn't being wound up today... and if they can repay £5m to trustees/bond holders per annum, and the enterprise value stays constant, that's £5m that moves from the liability pot into equity holders hands each year. With 74m shares, that's worth about 7 pence a year. With a share price of 10p, I suspect most people would be quite happy with that level of return pa, growth or no growth :)
valuschmalu: Pension trustees really need to get a shifty on and agree the deficit contributions pronto. The more they dither and the more share price drifts lower, the more likely credit insurance is pulled for suppliers and you enter the death spiral. If they stand behind the company there is a chance company recovers and pensions can be paid in full. If it does down, deferred pensioners will take a guaranteed haircut on their pensions
valuschmalu: You would have to think there will be a decent pop up in the share price tomorrow morning. Ends the day 14-15p?
boadicea: Well, that substantially clears the way forward at some apparent cost but I haven't evaluated that yet. At a quick glance it looks possibly sustainable with a fair wind, i.e. continued good profitabiity in the retained entities. I am assuming banks etc are fully in the picture and have given the nod to continuing support on the chosen path.
dangersimpson2: I agree that there is some asymmetry in the pension liabilities - the equity in the company cannot be worth less than zero. But it is a real debt that will take cash that would otherwise accrue to equity holders. The increase in the pension deficit of c£20m recently is a real killer because it has happened when the company is financially weak. I think £70-80m is a pretty punchy valuation for the remaining businesses. Combined operating profit was £8.1m in FY19 but there are £2.9m of central costs unallocated. They will save something not having WIPAC, but not all of these. So say they save £1m and are left with £1.9m ongoing central costs. (They cannot sell of thee businesses and delist to save all the central costs because this would crystalise the pension deficit and a buyout valuation would be much higher than the £49.1 deficit.) So £6.2m EBITDA. c.7x EBITDA would seem reasonable giving more like a £40-50m valuation. Let's be generous and say £50m £26.6m Debt - £1m Czech Sale + £49.1m PD = £74.7m liabilities. So Equity Value = WIPAC Sale + £50m - £74.7m = WIPAC Sale - £24.7m So they need to get at least £25m for WIPAC for the equity to have any value, and more than £35m for the valuation to be above the current share price, and that is with some generous assumptions. The pessimistic view would be more like the £50m I mentioned originally. Yes, a £20m improvement in pension deficit and a WIPAC sale for c£15m would justify the current share price, or a sale of WIPAC for £30m would give a 3x, but it is the expected value that matters not just the ratio of downside to upside. If the probability of a £20m reduction in PD AND a sale of WIPAC for £30m is less than 25% then the expected value is still lower than the current price. Personally, I rate the combined probability of those events much lower than 25%, others may take a different view.
dangersimpson2: Interesting find, price is the big question. Given the c£80m size of the debt & pension deficit, I think they need to get at least £50m for WIPAC for the rest to be worth more than the current share price.
queeny2: Consort accept cash bid at 40% premium.Which is STILL well below their share price when they bid for Carclo.Don't get excited about that, please.
1gw: Speculation of course, but my guess would be that Consort overstretched themselves with the 13th July offer in order to get talking to Carclo. Carclo had said they would be prepared to discuss a proposal that they would be minded to recommend to shareholders so given they were discussing the 13th July proposal I think that must have been worth around 130p or more (given the 116p proposal was rejected out of hand). The Consort share price had fallen a bit between their proposals, so the "cost" to them in Consort shares would have gone up more than the headline price difference in the proposals. With Consort now presumably having seen the books, I think the Consort walk-away is telling us that Consort don't believe they can make a reasonable return on their investment in Carclo at their 13th July proposal level. I don't think the strategic benefits would have changed so I think that's down to the perceived value of synergies, maybe the resale value of Wipac and maybe also further thought about the pension deficit. Given the synergies aren't available to Carclo on a standalone basis, that would seem to put a medium-term cap on the value of Carclo, unless they can achieve significantly more value from Wipac than was implicit in the Consort proposal. Equally, for reasons discussed on this board before, it's quite difficult to see a white knight seeing much more value in Carclo than Consort could. Since we don't know the level of the Consort revised proposal, it's difficult to say what that cap is. But we can fall back perhaps on the 2nd July Carclo statement that the 116p proposal "in no way reflected the fundamental value of the Company". So now I imagine institutional holders will be putting pressure on the Carclo board to take actions in the near term which get the share price closer to that fundamental value that the board claim to see. It's good to see that Axxion continued to buy post deal-collapse, buying on both the 7th and yesterday. It would be nice to see other shareholders and indeed the board themselves showing confidence in the board's valuation and adding to their holdings while the shareprice remains below 116p.
Carclo share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200606 04:48:41